Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 17.576
Filter
1.
Georgian Med News ; (350): 133-137, 2024 May.
Article in English | MEDLINE | ID: mdl-39089285

ABSTRACT

Hyperglycemia and hyperinsulinemia in type 2 diabetes result in complications exacerbated by oxidative stress, leading to cardiovascular, nephropathic, neuropathic, and retinopathic problems. Substance P(SP), a natural neuropeptide, inhibits cell death and enhances cell growth during oxidative or inflammatory stress, suggesting a potential role in reducing diabetic complications. Objective -investigate serum levels of SP, total antioxidant status (TAS), glycemic measures, and lipid profiles in non-obese type 2 diabetic patients and evaluate the relationships involving these biomarkers. MATERIAL AND METHOD: A case-control study involved 85 adult subjects (46males & 39females), aged (30-60) year, included two groups; diabetic group:53(males & females) non-obese type 2 diabetic patients, healthy group: Apparently healthy subjects of 32 individuals chosen from the general population and matched with patients age, sex and BMI. RESULTS: The results showed that patients' glucose levels increased as percentage increase of (˃141%),mild elevated insulin levels (˃50%), higher insulin resistance (˃250%), the lipid parameters exhibited disruption in comparison to the control group, in diabetic group, the serum levels of TAS, SP decreased considerably in comparison to the control group. CONCLUSION: As evidenced by the outcomes; the TAS showed significant negative correlations with fasting serum glucose and low-density lipoprotein, and positive correlations with high-density lipoprotein. Neither the glycemic indices nor the lipid profiles or TAS demonstrated any notable associations with SP levels. This suggests that while SP levels are reduced in type 2 diabetes, they do not appear to be directly linked with the measured biomarkers.


Subject(s)
Antioxidants , Biomarkers , Blood Glucose , Diabetes Mellitus, Type 2 , Substance P , Humans , Diabetes Mellitus, Type 2/blood , Female , Male , Middle Aged , Adult , Substance P/blood , Biomarkers/blood , Case-Control Studies , Antioxidants/metabolism , Blood Glucose/metabolism , Insulin Resistance , Oxidative Stress , Insulin/blood
2.
Sci Immunol ; 9(98): eadh0545, 2024 Aug 23.
Article in English | MEDLINE | ID: mdl-39178277

ABSTRACT

Postoperative pain affects most patients after major surgery and can transition to chronic pain. The considerable side effects and limited efficacy of current treatments underline the need for new therapeutic options. We observed increased amounts of the metabolites BH4 and serotonin after skin injury. Mast cells were primary postoperative sources of Gch1, the rate-limiting enzyme in BH4 synthesis, itself an obligate cofactor in serotonin production by tryptophan hydroxylase (Tph1). Mice deficient in mast cells or in mast cell-specific Gch1 or Tph1 showed drastically decreased postoperative pain. We found that injury induced the nociceptive neuropeptide substance P, mast cell degranulation, and granule nerve colocalization. Substance P triggered serotonin release in mouse and human mast cells, and substance P receptor blockade substantially ameliorated pain hypersensitivity. Our findings highlight the importance of mast cells at the neuroimmune interface and substance P-driven mast cell BH4 and serotonin production as a therapeutic target for postoperative pain treatment.


Subject(s)
Mast Cells , Pain, Postoperative , Serotonin , Mast Cells/immunology , Serotonin/metabolism , Animals , Pain, Postoperative/immunology , Mice , Humans , Mice, Inbred C57BL , Substance P/metabolism , Male , Mice, Knockout , Tryptophan Hydroxylase/metabolism
3.
Pol Przegl Chir ; 96(4): 15-24, 2024 Feb 08.
Article in English | MEDLINE | ID: mdl-39138987

ABSTRACT

<b>Introduction:</b> Previous studies indicate a significant role of the inflammatory response in the etiopathogenesis of peripheral artery disease (PAD) and chronic pain (CP).<b>Aim:</b> The aim of the study was to determine the relationship between the concentration of SP and the level/concentration of inflammatory mediators (pro-inflammatory cytokines, positive and negative acute phase protein, anti-inflammatory cytokines) and pain intensity in people suffering from chronic pain (CP) in the course of PAD.<b>Material and methods:</b> We examined 187 patients of the Department of Vascular Surgery. As many as 92 patients with PAD and CP (study group) were compared to 95 patients with PAD without CP (control group). The relationship between SP and the level/concentration of fibrinogen, C-reactive protein (CRP), antithrombin III (AT), serum albumin, interleukin 10 (IL-10), tumor necrosis factor alpha (TNF-α) and pain intensity (Numeric Rating Scale; NRS) was analyzed. Statistical analysis was performed using the R program, assuming the level of statistical significance of α = 0.05.<b>Results:</b> Patients with CP had significantly higher levels of fibrinogen (P < 0.001), CRP (P < 0.001), SP (P < 0.001), IL-10 (P < 0.001), and lower serum albumin levels (P < 0.023). Higher SP concentration was associated with higher levels of IL-10, CRP, and pain intensity. In both groups, SP concentration correlated negatively with the level of fibrinogen (P < 0.001) as well as with albumin in the control group (P < 0.001).<b>Conclusions:</b> Thus, there is a relationship between the concentration of SP and fibrinogen, along with CRP, IL-10, and the intensity of pain in people suffering from CP in the course of PAD, and the level of albumin in the group without CP.


Subject(s)
Chronic Pain , Peripheral Arterial Disease , Substance P , Humans , Female , Male , Peripheral Arterial Disease/blood , Peripheral Arterial Disease/complications , Middle Aged , Aged , Chronic Pain/blood , Substance P/blood , C-Reactive Protein/analysis , C-Reactive Protein/metabolism , Pain Perception/physiology , Interleukin-10/blood , Inflammation/blood , Fibrinogen/analysis , Fibrinogen/metabolism , Pain Measurement , Biomarkers/blood , Tumor Necrosis Factor-alpha/blood
4.
Sci Rep ; 14(1): 19511, 2024 08 22.
Article in English | MEDLINE | ID: mdl-39174615

ABSTRACT

The objectives of this prospective, randomized, blinded, crossover, experimental study were to detect the potential anaesthetic- and analgesic-sparing effects of classical music provided to dogs undergoing skin surgery, and to investigate the role of substance P as an intraoperative pain indicator. Twenty dogs were included, each subjected to three different treatments: Chopin music, Mozart music and no music. They were premedicated with acepromazine, butorphanol and meloxicam and anaesthetized with propofol and isoflurane. Fentanyl was used as rescue analgesia. The anaesthetic depth was monitored by using the bispectral index along with standard anaesthetic monitoring, and autonomic nervous system responses were used to monitor the adequacy of analgesia. Furthermore, measurements of substance P serum concentration were carried out. Dogs exposed to music required less isoflurane and fentanyl. Furthermore, a statistically significant effect of time on substance P concentration was observed regardless of exposure to music, and there was a significant interaction effect between different timepoints and the type of acoustic stimulus. Classical music seems to have an isoflurane and fentanyl sparing effect on dogs undergoing minor surgery. Following surgical stimulation, the serum substance P concentration increases rapidly, and thus appears to be a potentially useful pain indicator.


Subject(s)
Substance P , Animals , Dogs , Substance P/blood , Analgesia/methods , Music , Fentanyl/pharmacology , Male , Isoflurane/pharmacology , Female , Anesthesia/methods , Cross-Over Studies , Prospective Studies , Nociception/drug effects , Propofol/pharmacology , Propofol/administration & dosage
5.
Nutrients ; 16(14)2024 Jul 14.
Article in English | MEDLINE | ID: mdl-39064711

ABSTRACT

Plastics are present in almost every aspect of our lives. Polyethylene terephthalate (PET) is commonly used in the food industry. Microparticles can contaminate food and drinks, posing a threat to consumers. The presented study aims to determine the effect of microparticles of PET on the population of neurons positive for selected neurotransmitters in the enteric nervous system of the jejunum and histological structure. An amount of 15 pigs were divided into three groups (control, receiving 0.1 g, and 1 g/day/animal orally). After 28 days, fragments of the jejunum were collected for immunofluorescence and histological examination. The obtained results show that histological changes (injury of the apical parts of the villi, accumulations of cellular debris and mucus, eosinophil infiltration, and hyperaemia) were more pronounced in pigs receiving a higher dose of microparticles. The effect on neuronal nitric oxide synthase-, and substance P-positive neurons, depends on the examined plexus and the dose of microparticles. An increase in the percentage of galanin-positive neurons and a decrease in cocaine and amphetamine-regulated transcript-, vesicular acetylcholine transporter-, and vasoactive intestinal peptide-positive neurons do not show such relationships. The present study shows that microparticles can potentially have neurotoxic and pro-inflammatory effects, but there is a need for further research to determine the mechanism of this process and possible further effects.


Subject(s)
Jejunum , Microplastics , Neurons , Animals , Jejunum/drug effects , Jejunum/metabolism , Swine , Microplastics/toxicity , Neurons/drug effects , Neurons/metabolism , Enteric Nervous System/drug effects , Enteric Nervous System/metabolism , Substance P/metabolism , Vasoactive Intestinal Peptide/metabolism , Polyethylene Terephthalates , Nitric Oxide Synthase Type I/metabolism , Galanin/metabolism , Neuronal Plasticity/drug effects , Administration, Oral , Neurotransmitter Agents/metabolism , Vesicular Acetylcholine Transport Proteins/metabolism , Male , Nerve Tissue Proteins
6.
Int J Mol Sci ; 25(14)2024 Jul 13.
Article in English | MEDLINE | ID: mdl-39062944

ABSTRACT

Polysulfides are endogenously produced in mammals and generally associated with protective functions. Our aim was to investigate the effect of dimethyl trisulfide (DMTS) in a mouse model of acute stress. DMTS activates transient receptor potential ankyrin 1 (TRPA1) channels and leads to neuropeptide release, potentially that of substance P (SP). We hypothesize that DMTS might inhibit the degrading enzymes of endocannabinoids, so this system was also investigated as another possible pathway for mediating the effects of DMTS. Trpa1 gene wild-type (WT) and knockout (KO) mice were used to confirm the role of the TRPA1 ion channel in mediating the effects of DMTS. C57BL/6J, NK1 gene KO, and Tac1 gene KO mice were used to evaluate the effect of DMTS on the release and expression of SP. Some C57BL/6J animals were treated with AM251, an inhibitor of the cannabinoid CB1 receptor, to elucidate the role of the endocannabinoid system in these processes. Open field test (OFT) and forced swim test (FST) were performed in each mouse strain. A tail suspension test (TST) was performed in Trpa1 WT and KO animals. C-FOS immunohistochemistry was carried out on Trpa1 WT and KO animals. The DMTS treatment increased the number of highly active periods and decreased immobility time in the FST in WT animals, but had no effect on the Trpa1 KO mice. The DMTS administration induced neuronal activation in the Trpa1 WT mice in the stress-related brain areas, such as the locus coeruleus, dorsal raphe nucleus, lateral septum, paraventricular nucleus of the thalamus, and paraventricular nucleus of the hypothalamus. DMTS may have a potential role in the regulation of stress-related processes, and the TRPA1 ion channel may also be involved in mediating the effects of DMTS. DMTS can be an ideal candidate for further study as a potential remedy for stress-related disorders.


Subject(s)
Disease Models, Animal , Mice, Inbred C57BL , Mice, Knockout , Sulfides , TRPA1 Cation Channel , Animals , TRPA1 Cation Channel/metabolism , TRPA1 Cation Channel/genetics , Mice , Sulfides/pharmacology , Male , Substance P/metabolism , Stress, Psychological/metabolism , Stress, Physiological/drug effects , Proto-Oncogene Proteins c-fos/metabolism
7.
Int J Mol Sci ; 25(13)2024 Jun 25.
Article in English | MEDLINE | ID: mdl-39000048

ABSTRACT

Bisphenols are dangerous endocrine disruptors that pollute the environment. Due to their chemical properties, they are globally used to produce plastics. Structural similarities to oestrogen allow bisphenols to bind to oestrogen receptors and affect internal body systems. Most commonly used in the plastic industry is bisphenol A (BPA), which also has negative effects on the nervous, immune, endocrine, and cardiovascular systems. A popular analogue of BPA-bisphenol S (BPS) also seems to have harmful effects similar to BPA on living organisms. Therefore, with the use of double immunofluorescence labelling, this study aimed to compare the effect of BPA and BPS on the enteric nervous system (ENS) in mouse jejunum. The study showed that both studied toxins impact the number of nerve cells immunoreactive to substance P (SP), galanin (GAL), vasoactive intestinal polypeptide (VIP), the neuronal isoform of nitric oxide synthase (nNOS), and vesicular acetylcholine transporter (VAChT). The observed changes were similar in the case of both tested bisphenols. However, the influence of BPA showed stronger changes in neurochemical coding. The results also showed that long-term exposure to BPS significantly affects the ENS.


Subject(s)
Benzhydryl Compounds , Enteric Nervous System , Jejunum , Phenols , Sulfones , Animals , Phenols/toxicity , Benzhydryl Compounds/toxicity , Mice , Jejunum/drug effects , Jejunum/metabolism , Enteric Nervous System/drug effects , Enteric Nervous System/metabolism , Sulfones/pharmacology , Sulfones/toxicity , Substance P/metabolism , Vasoactive Intestinal Peptide/metabolism , Vesicular Acetylcholine Transport Proteins/metabolism , Male , Galanin/metabolism , Endocrine Disruptors/toxicity , Endocrine Disruptors/pharmacology , Nitric Oxide Synthase Type I/metabolism
8.
Int J Mol Sci ; 25(11)2024 May 28.
Article in English | MEDLINE | ID: mdl-38892091

ABSTRACT

Substance P (SP) plays a crucial role in pain modulation, with significant implications for major depressive disorder (MDD), anxiety disorders, and post-traumatic stress disorder (PTSD). Elevated SP levels are linked to heightened pain sensitivity and various psychiatric conditions, spurring interest in potential therapeutic interventions. In chronic pain, commonly associated with MDD and anxiety disorders, SP emerges as a key mediator in pain and emotional regulation. This review examines SP's impact on pain perception and its contributions to MDD, anxiety disorders, and PTSD. The association of SP with increased pain sensitivity and chronic pain conditions underscores its importance in pain modulation. Additionally, SP influences the pathophysiology of MDD, anxiety disorders, and PTSD, highlighting its potential as a therapeutic target. Understanding SP's diverse effects provides valuable insights into the mechanisms underlying these psychiatric disorders and their treatment. Further research is essential to explore SP modulation in psychiatric disorders and develop more effective treatment strategies.


Subject(s)
Chronic Pain , Depressive Disorder, Major , Stress Disorders, Post-Traumatic , Substance P , Humans , Chronic Pain/psychology , Substance P/metabolism , Depressive Disorder, Major/metabolism , Depressive Disorder, Major/physiopathology , Stress Disorders, Post-Traumatic/metabolism , Anxiety Disorders , Animals , Mental Disorders/metabolism
9.
Neuromuscul Disord ; 41: 20-23, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38865916

ABSTRACT

Inclusion body myositis is the commonest acquired myopathy in those over 50 years of age. Although it is classified as an idiopathic inflammatory myopathy and the most frequent finding on muscle biopsy in inclusion body myositis is an endomysial inflammatory infiltrate, it is clinically distinct from other myositis, including a lack of response to immunosuppressive medication. Neurogenic changes are commonly reported in inclusion body myositis and inflammatory changes are observed in muscle following neurogenic injury. The objective of our study was to explore whether neurogenic inflammation plays a role in the pathogenesis of inclusion body myositis, possibly explaining its resistance to immunosuppression. The number of mast cells and presence of neuropeptides, substance P and calcitonin gene-related peptide, were assessed in 48 cases of inclusion body myositis, 11 cases of steroid responsive myositis, two cases of focal myositis associated with neurogenic injury, and ten normal controls. The number of mast cells in inclusion body myositis focal and myositis associated to neurogenic injury were significantly greater than that observed in steroid responsive myositis. Our findings suggest that neurogenic inflammation mediated through mast cells may play a role in the pathogenesis of inclusion body myositis, and focal myositis associated to neurogenic injury, and thus, explain in some part its lack of response to immunosuppressive treatments.


Subject(s)
Mast Cells , Myositis, Inclusion Body , Humans , Myositis, Inclusion Body/pathology , Myositis, Inclusion Body/drug therapy , Mast Cells/pathology , Mast Cells/drug effects , Female , Middle Aged , Male , Aged , Aged, 80 and over , Substance P/metabolism , Muscle, Skeletal/pathology , Calcitonin Gene-Related Peptide/metabolism , Adult , Immunosuppressive Agents/therapeutic use , Immunosuppressive Agents/pharmacology
10.
Int Immunopharmacol ; 137: 112490, 2024 Aug 20.
Article in English | MEDLINE | ID: mdl-38897121

ABSTRACT

BACKGROUND: Vitamin K3 (VK3), a fat-soluble synthetic analog of the vitamin K family, has coagulant, anti-inflammatory, antibacterial, and anticancer properties. Pseudo allergy is a IgE-independent immune response associated with mast cells. This study investigated the role of VK3 in IgE-independent mast cell activation. METHODS: Substance P (SP) was used to induce LAD2-cell activation in order to analyze the effects of VK3 in vitro. Cutaneous allergy and systemic allergy mouse models were used to analyze the anti-pseudo-allergic effects of VK3. Proteome microarray assays were used to analyze VK3-binding protein. Biolayer interferometry and immunoprecipitation were used to verify interaction between VK3 and its key targets. RNA interference was used to determine the role of GAB1 in LAD2cell activation. RESULTS: VK3 inhibited SP-induced LAD2-cell activation, and resulted in the release of ß-hexosaminidase, histamine and cytokines; VK3 inhibited SP-induced pseudo allergic reactions in mice, and serum histamine and TNF-α levels decreased. Degranulation of skin mast cells was reduced; GAB1 in mast cells was stably bound to VK3. GAB1 participated in SP-induced LAD2-cell activation. GAB1 knockdown in LAD2 cells prevented SP-induced ß-hexosaminidase release, calcium mobilization and cell skeletal remodeling. VK3 directly binds to GAB1 and reduces its expression to inhibited SP-induced LAD2 cell activation. CONCLUSION: The anti-pseudo-allergic activity of VK3 was confirmed in vitro and in vivo. VK3 can inhibit SP-induced mast cell activation by directly targeting GAB1. This study provides new insights on the activity of VK3 and the mechanism of pseudoallergic reaction.


Subject(s)
Adaptor Proteins, Signal Transducing , Mast Cells , Mast Cells/immunology , Mast Cells/drug effects , Animals , Adaptor Proteins, Signal Transducing/metabolism , Adaptor Proteins, Signal Transducing/genetics , Mice , Humans , Substance P/metabolism , Cell Degranulation/drug effects , Mice, Inbred BALB C , Hypersensitivity/immunology , Hypersensitivity/drug therapy , Anti-Allergic Agents/pharmacology , Anti-Allergic Agents/therapeutic use , Female , Cell Line , beta-N-Acetylhexosaminidases/metabolism , Disease Models, Animal
11.
Int J Mol Sci ; 25(12)2024 Jun 13.
Article in English | MEDLINE | ID: mdl-38928206

ABSTRACT

Substance P (SP), encoded by the Tac1 gene, has been shown to promote leukocyte infiltration and organ impairment in mice with sepsis. Neurokinin-1 receptor (NK1R) is the major receptor that mediates the detrimental impact of SP on sepsis. This investigation studied whether SP affects the expression of adhesion molecules, including intercellular cell adhesion molecule-1 (ICAM1) and vascular cell adhesion molecule-1 (VCAM1) on vascular endothelial cells in the liver and lungs, contributing to leukocyte infiltration in these tissues of mice with sepsis. Sepsis was induced by caecal ligation and puncture (CLP) surgery in mice. The actions of SP were inhibited by deleting the Tac1 gene, blocking NK1R, or combining these two methods. The activity of myeloperoxidase and the concentrations of ICAM1 and VCAM1 in the liver and lungs, as well as the expression of ICAM1 and VCAM1 on vascular endothelial cells in these tissues, were measured. The activity of myeloperoxidase and the concentration of ICAM1 and VCAM1 in the liver and lungs, as well as the expression of ICAM1 and VCAM1 on vascular endothelial cells in these tissues, increased in mice with CLP surgery-induced sepsis. Suppressing the biosynthesis of SP and its interactions with NK1R attenuated CLP surgery-induced alterations in the liver and lungs of mice. Our findings indicate that SP upregulates the expression of ICAM1 and VCAM1 on vascular endothelial cells in the liver and lungs, thereby increasing leukocyte infiltration in these tissues of mice with CLP surgery-induced sepsis by activating NK1R.


Subject(s)
Endothelial Cells , Intercellular Adhesion Molecule-1 , Liver , Lung , Receptors, Neurokinin-1 , Sepsis , Substance P , Vascular Cell Adhesion Molecule-1 , Animals , Sepsis/metabolism , Sepsis/pathology , Mice , Substance P/metabolism , Lung/metabolism , Lung/pathology , Liver/metabolism , Liver/pathology , Intercellular Adhesion Molecule-1/metabolism , Intercellular Adhesion Molecule-1/genetics , Endothelial Cells/metabolism , Vascular Cell Adhesion Molecule-1/metabolism , Vascular Cell Adhesion Molecule-1/genetics , Receptors, Neurokinin-1/metabolism , Receptors, Neurokinin-1/genetics , Male , Leukocytes/metabolism , Mice, Inbred C57BL , Peroxidase/metabolism , Cell Adhesion Molecules/metabolism , Cell Adhesion Molecules/genetics , Disease Models, Animal
12.
Sci Rep ; 14(1): 13890, 2024 06 17.
Article in English | MEDLINE | ID: mdl-38880787

ABSTRACT

Cryotherapy is widely utilized in medicine, particularly for pain management. This randomized clinical trial aimed to assess the effect of intraoral cold pack application (cryotherapy) on postoperative pain (POP) and the level of Substance P (SP) in patients with symptomatic apical periodontitis (SAP). Enrolled patients were randomly assigned to either cryotherapy or control group. After adequate anesthesia, access cavity, and biomechanical preparation of the root canal system were completed, the first apical fluid (AF) sample (S1) was obtained. A custom-made intraoral ice-gel pack was applied for 30 min in the cryotherapy group, while no intervention was performed in the control group. The second AF sample (S2) was collected 30 min later in both groups. Patients were asked to complete the Visual Analogue Scale (VAS) questionnaire to assess their POP. Quantification of SP in AF samples was performed using the enzyme-linked immunosorbent assay (ELISA) test. Data were analyzed statistically, revealing a significant reduction in POP and SP levels in the cryotherapy group compared to the control group (P ≤ 0.05). Furthermore, a moderate positive correlation was observed between SP levels and POP (P ≤ 0.05). In conclusion, intraoral cryotherapy represents a simple and cost-effective option for controlling POP and reducing inflammation levels in patients with SAP.


Subject(s)
Cryotherapy , Pain, Postoperative , Periapical Periodontitis , Substance P , Humans , Substance P/metabolism , Cryotherapy/methods , Female , Periapical Periodontitis/therapy , Periapical Periodontitis/surgery , Male , Pain, Postoperative/therapy , Adult , Middle Aged , Pain Measurement , Pain Management/methods
13.
Sci Rep ; 14(1): 13540, 2024 06 12.
Article in English | MEDLINE | ID: mdl-38866832

ABSTRACT

Mast cells are immune cells minimally present in normal tendon tissue. The increased abundance of mast cells in tendinopathy biopsies and at the sites of tendon injury suggests an unexplored role of this cell population in overuse tendon injuries. Mast cells are particularly present in tendon biopsies from patients with more chronic symptom duration and a history of intensive mechanical loading. This study, therefore, examined the cross talk between mast cells and human tendon cells in either static or mechanically active conditions in order to explore the potential mechanistic roles of mast cells in overuse tendon injuries. A coculture of isolated human tenocytes and mast cells (HMC-1) combined with Flexcell Tension System for cyclic stretching of tenocytes was used. Additionally, human tenocytes were exposed to agonists and antagonists of substance P (SP) receptors. Mast cell degranulation was assessed by measuring ß-hexosaminidase activity. Transwell and cell adhesion assays were used to evaluate mast cell migration and binding to tendon extracellular matrix components (collagen and fibronectin), respectively. Gene expressions were analyzed using real time qRT-PCR. Our results indicate that mechanical stimulation of human tenocytes leads to release of SP which, in turn, activates mast cells through the Mas-related G-protein-coupled receptor X2 (MRGPRX2). The degranulation and migration of mast cells in response to MRGPRX2 activation subsequently cause human tenocytes to increase their expression of inflammatory factors, matrix proteins and matrix metalloproteinase enzymes. These observations may be important in understanding the mechanisms by which tendons become tendinopathic in response to repetitive mechanical stimulation.


Subject(s)
Mast Cells , Receptors, G-Protein-Coupled , Receptors, Neuropeptide , Substance P , Tendons , Tenocytes , Humans , Substance P/metabolism , Substance P/pharmacology , Mast Cells/metabolism , Tenocytes/metabolism , Receptors, G-Protein-Coupled/metabolism , Receptors, Neuropeptide/metabolism , Receptors, Neuropeptide/genetics , Tendons/metabolism , Tendons/pathology , Nerve Tissue Proteins/metabolism , Nerve Tissue Proteins/genetics , Cell Degranulation , Tendinopathy/metabolism , Tendinopathy/pathology , Inflammation/metabolism , Inflammation/pathology , Male , Coculture Techniques , Cells, Cultured , Adult , Cell Movement
14.
J Am Soc Mass Spectrom ; 35(7): 1461-1469, 2024 Jul 03.
Article in English | MEDLINE | ID: mdl-38835173

ABSTRACT

In a hydrogen exchange-mass spectrometry (HX-MS) experiment, the enzymatic proteolysis of the deuterated protein is an essential step. Often the differences in the performance between different digestion protocols or between immobilized protease columns can be challenging to evaluate. To compare differences in the performance of immobilized protease columns, a new digestion efficiency metric known as digestible peptide scoring (DPS) was developed and is presented in this work. The measured response fraction of substance P peptide is used to assign a value between 0% and 100% based on the fraction of substance P digested by the enzyme, using angiotensin II as an undigested internal standard. In this work, the DPS approach was tested using multiple immobilized pepsin batches prepared using different protocols. The results demonstrate the repeatability of DPS values for batches prepared using the same conditions and the ability of the DPS evaluations to provide unique values when the immobilization conditions were altered. Protein digestions obtained with a higher scoring column were better than digestions obtained using a lower scoring column. The DPS evaluation is simple and quickly provides an unambiguous assessment which can be used to evaluate an immobilized enzyme column's suitability prior to performing an experiment, to track performance over a column's lifetime, to optimize protease immobilization protocols specifically for the quench conditions of a particular experiment, and to optimize the digestion conditions.


Subject(s)
Pepsin A , Proteolysis , Pepsin A/metabolism , Pepsin A/chemistry , Peptides/chemistry , Peptides/analysis , Peptides/metabolism , Hydrogen Deuterium Exchange-Mass Spectrometry/methods , Substance P/chemistry , Substance P/metabolism , Substance P/analysis , Enzymes, Immobilized/chemistry , Enzymes, Immobilized/metabolism
15.
Neuroreport ; 35(11): 692-701, 2024 Aug 07.
Article in English | MEDLINE | ID: mdl-38874969

ABSTRACT

OBJECTIVE: Diabetic neuropathic pain (DNP) is one of the most prevalent symptoms of diabetes. The alteration of proteins in the spinal cord dorsal horn (SCDH) plays a significant role in the genesis and the development of DNP. Our previous study has shown electroacupuncture could effectively relieve DNP. However, the potential mechanism inducing DNP's genesis and development remains unclear and needs further research. METHODS: This study established DNP model rats by intraperitoneally injecting a single high-dose streptozotocin; 2 Hz electroacupuncture was used to stimulate Zusanli (ST36) and Kunlun (BL60) of DNP rats daily from day 15 to day 21 after streptozotocin injection. Behavioral assay, quantitative PCR, immunofluorescence staining, and western blotting were used to study the analgesic mechanism of electroacupuncture. RESULTS: The bradykinin B1 receptor (B1R) mRNA, nuclear factor-κB p65 (p65), substance P, and calcitonin gene-related peptide (CGRP) protein expression were significantly enhanced in SCDH of DNP rats. The paw withdrawal threshold was increased while body weight and fasting blood glucose did not change in DNP rats after the electroacupuncture treatment. The expression of B1R, p65, substance P, and CGRP in SCDH of DNP rats was also inhibited after the electroacupuncture treatment. CONCLUSION: This work suggests that the potential mechanisms inducing the allodynia of DNP rats were possibly related to the increased expression of B1R, p65, substance P, and CGRP in SCDH. Downregulating B1R, p65, substance P, and CGRP expression levels in SCDH may achieve the analgesic effect of 2 Hz electroacupuncture treatment.


Subject(s)
Diabetes Mellitus, Experimental , Down-Regulation , Electroacupuncture , Hyperalgesia , Rats, Sprague-Dawley , Receptor, Bradykinin B1 , Spinal Cord Dorsal Horn , Animals , Electroacupuncture/methods , Male , Spinal Cord Dorsal Horn/metabolism , Hyperalgesia/therapy , Hyperalgesia/metabolism , Diabetes Mellitus, Experimental/therapy , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/complications , Receptor, Bradykinin B1/metabolism , Receptor, Bradykinin B1/genetics , Diabetic Neuropathies/metabolism , Diabetic Neuropathies/therapy , Rats , Calcitonin Gene-Related Peptide/metabolism , Calcitonin Gene-Related Peptide/genetics , Substance P/metabolism
16.
Int J Mol Sci ; 25(11)2024 May 24.
Article in English | MEDLINE | ID: mdl-38891925

ABSTRACT

Stress exposure worsens allergic inflammatory diseases substantially. Mast cells (MCs) play a key role in peripheral immune responses to neuroendocrine stress mediators such as nerve growth factor (NGF) and substance P (SP). Mast cell proteases (MCPs) and cholinergic factors (Chrna7, SLURP1) were recently described to modulate MC stress response. We studied MCPs and Chrna7/SLURP1 and their interplay in a mouse model for noise induced stress (NiS) and atopic dermatitis-like allergic inflammation (AlD) and in cultured MC lacking Chrna7. We found that the cholinergic stress axis interacts with neuroendocrine stress mediators and stress-mediator cleaving enzymes in AlD. SP-cleaving mMCP4+ MC were upregulated in AlD and further upregulated by stress in NiS+AlD. Anti-NGF neutralizing antibody treatment blocked the stress-induced upregulation in vivo, and mMCP4+ MCs correlated with measures of AlD disease activity. Finally, high mMCP4 production in response to SP depended on Chrna7/SLURP1 in cultured MCs. In conclusion, mMCP4 and its upstream regulation by Chrna7/SLURP1 are interesting novel targets for the treatment of allergic inflammation and its aggravation by stress.


Subject(s)
Dermatitis, Atopic , Disease Models, Animal , Mast Cells , Skin , alpha7 Nicotinic Acetylcholine Receptor , Animals , Mast Cells/metabolism , Mast Cells/immunology , Dermatitis, Atopic/metabolism , Dermatitis, Atopic/pathology , Dermatitis, Atopic/immunology , Mice , Skin/metabolism , Skin/pathology , alpha7 Nicotinic Acetylcholine Receptor/metabolism , Inflammation/metabolism , Inflammation/pathology , Peptide Hydrolases/metabolism , Urokinase-Type Plasminogen Activator/metabolism , Substance P/metabolism , Stress, Physiological , Mice, Inbred C57BL , Nerve Growth Factor/metabolism
17.
Am J Physiol Cell Physiol ; 327(1): C151-C167, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38798270

ABSTRACT

Substance P (SP) is released from sensory nerves in the arteries and heart. It activates neurokinin-1 receptors (NK1Rs) causing vasodilation, immune modulation, and adverse cardiac remodeling. The hypothesis was tested: SP and SP metabolites activate different second messenger signaling pathways. Macrophages, endothelial cells, and fibroblasts metabolized SP to N- and C-terminal metabolites to varying extents. SP 5-11 was the most abundant metabolite followed by SP 1-4, SP 7-11, SP 6-11, SP 3-11, and SP 8-11. In NK1R-expressing human embryonic kidney 293 (HEK293) cells, SP and some C-terminal SP metabolites stimulate the NK1R, promoting the dissociation of several Gα proteins, including Gαs and Gαq from their ßγ subunits. SP increases intracellular calcium concentrations ([Ca]i) and cyclic 3',5'-adenosine monophosphate (cAMP) accumulation with similar -log EC50 values of 8.5 ± 0.3 and 7.8 ± 0.1 M, respectively. N-terminal metabolism of SP by up to five amino acids and C-terminal deamidation of SP produce peptides that retain activity to increase [Ca]i but not to increase cAMP. C-terminal metabolism results in the loss of both activities. Thus, [Ca]i and cAMP signaling are differentially affected by SP metabolism. To assess the role of N-terminal metabolism, SP and SP 6-11 were compared with cAMP-mediated activities in NK1R-expressing 3T3 fibroblasts. SP inhibits nuclear factor κB (NF-κB) activity, cell proliferation, and wound healing and stimulates collagen production. SP 6-11 had little or no activity. Cyclooxygenase-2 (COX-2) expression is increased by SP but not by SP 6-11. Thus, metabolism may select the cellular response to SP by inhibiting or redirecting the second messenger signaling pathway activated by the NK1R.NEW & NOTEWORTHY Endothelial cells, macrophages, and fibroblasts metabolize substance P (SP) to N- and C-terminal metabolites with SP 5-11 as the most abundant metabolite. SP activates neurokinin-1 receptors to increase intracellular calcium and cyclic AMP. In contrast, SP metabolites of N-terminal metabolism and C-terminal deamidation retain the ability to increase calcium but lose the ability to increase cyclic AMP. These new insights indicate that the metabolism of SP directs cellular functions by regulating specific signaling pathways.


Subject(s)
Cyclic AMP , Receptors, Neurokinin-1 , Signal Transduction , Substance P , Substance P/metabolism , Receptors, Neurokinin-1/metabolism , Receptors, Neurokinin-1/agonists , Humans , Cyclic AMP/metabolism , Animals , HEK293 Cells , Mice , Fibroblasts/metabolism , Fibroblasts/drug effects , Calcium/metabolism
18.
Ann Anat ; 255: 152291, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38821428

ABSTRACT

BACKGROUND: What textbooks usually call the sublingual gland in humans is in reality a tissue mass of two types of salivary glands, the anteriorly located consisting of a cluster of minor sublingual glands and the posteriorly located major sublingual gland with its outlet via Bartholin's duct. Only recently, the adrenergic and cholinergic innervations of the major sublingual gland was reported, while information regarding the neuropeptidergic and nitrergic innervations is still lacking. METHODS: Bioptic and autoptic specimens of the human major sublingual gland were examined by means of immunohistochemistry for the presence of vasoactive intestinal peptide (VIP)-, neuropeptide Y (NPY)-, substance P (SP)-, calcitonin gene related-peptide (CGRP)-, and neuronal nitric oxide synthase (nNOS)-labeled neuronal structures. RESULTS: As to the neuropeptidergic innervation of secretory cells (here in the form of mucous tubular and seromucous cells), the findings showed many VIP-containing nerves, few NPY- and SP-containing nerves and a lack of CGRP-labeled nerves. As to the neuropeptidergic innervation of vessels, the number of VIP-containing nerves was modest, while, of the other neuropeptide-containing nerves under study, only few (SP and CGRP) to very few (NPY) nerves were observed. As to the nitrergic innervation, nNOS-containing nerves were very few close to secretory cells and even absent around vessels. CONCLUSION: The various innervation patterns may suggest potential transmission mechanisms involved in secretory and vascular responses of the major sublingual gland.


Subject(s)
Neuropeptides , Sublingual Gland , Substance P , Humans , Sublingual Gland/innervation , Sublingual Gland/metabolism , Male , Neuropeptides/metabolism , Female , Substance P/metabolism , Neuropeptide Y/metabolism , Calcitonin Gene-Related Peptide/metabolism , Vasoactive Intestinal Peptide/metabolism , Immunohistochemistry , Middle Aged , Nitric Oxide Synthase Type I/metabolism , Aged , Adult , Aged, 80 and over
19.
World J Surg ; 48(7): 1662-1673, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38777749

ABSTRACT

BACKGROUND: The aim of this study was to establish features of inflammation in histologically normal gallbladders with gallstones and compare the expression of inflammatory markers in acutely and chronically inflamed gallbladders. METHODS: Immunohistochemistry was performed on formalin-fixed paraffin-embedded gallbladders for tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-2R, and substance p in three groups: Group I (n = 60) chronic cholecystitis, Group II (n = 57) acute cholecystitis and Group III (n = 45) histologically normal gallbladders with gallstones. Expression was quantified using the H-scoring system. RESULTS: Median, interquartile range expression of mucosal IL-2R in Groups I (2.65, 0.87-7.97) and II (12.30, 6.15-25.55) was significantly increased compared with group III (0.40, 0.10-1.35, p < 0.05). Submucosal IL-2R expression in Groups I (2.0, 1.12-4.95) and II (10.0, 5.95-14.30) was also significantly increased compared with Group III (0.50, 0.15-1.05, p < 0.05). There was no difference in the lymphoid cell IL-6 expression between Groups I (5.95, 1.60-18.15), II (6.10, 1.1-36.15) and III (8.30, 2.60-26.35, p > 0.05). Epithelial IL-6 expression of Group III (8.3, 2.6-26.3) was significantly increased compared with group I (0.5, 0-10.2, p < 0.05) as was epithelial TNF-α expression in Group III (85.0, 70.50-92.0) compared with Groups I (72.50, 45.25.0-85.50, p < 0.05) and II (61.0, 30.0-92.0, p < 0.05). Lymphoid cell Substance P expression in Groups I (1.90, 1.32-2.65) and II (5.62, 2.50-20.8) was significantly increased compared with Group III (1.0,1.0-1.30, p < 0.05). Epithelial cell expression of Substance P in Group III (121.7, 94.6-167.8) was significantly increased compared with Groups I (75.7, 50.6-105.3, p < 0.05) and II (78.9, 43.5-118.5, p < 0.05). CONCLUSION: Histologically normal gallbladders with gallstones exhibited features of inflammation on immunohistochemistry.


Subject(s)
Gallstones , Immunohistochemistry , Humans , Gallstones/pathology , Gallstones/metabolism , Male , Female , Middle Aged , Adult , Interleukin-6/metabolism , Tumor Necrosis Factor-alpha/metabolism , Tumor Necrosis Factor-alpha/analysis , Cholecystitis/pathology , Cholecystitis/metabolism , Substance P/metabolism , Gallbladder/pathology , Gallbladder/metabolism , Receptors, Interleukin-2/metabolism , Aged , Chronic Disease , Biomarkers/metabolism , Biomarkers/analysis , Cholecystitis, Acute/pathology , Cholecystitis, Acute/metabolism , Cholecystitis, Acute/surgery
20.
J Appl Oral Sci ; 32: e20240017, 2024.
Article in English | MEDLINE | ID: mdl-38775598

ABSTRACT

OBJECTIVE: To compare the effect of submucosal cryotherapy using cold saline to dexamethasone sodium phosphate and diclofenac sodium injections on substance P and interleukin 6 release in experimentally induced pulpal inflammation in rabbits' molar teeth. METHODOLOGY: Fifteen rabbits were randomly classified into 3 groups according to the submucosal injection given: cold saline, dexamethasone sodium phosphate, and diclofenac sodium. A split-mouth design was adopted, the right mandibular molars were experimental, and the left molars served as the control without injections. Intentional pulp exposures were created and left for 6 hours to induce pulpitis. Pulpal tissue was extracted and examined for SP and IL-6 levels using ELISA. Within each group, the level of cytokines released was measured for both control and experimental groups for intragroup comparison to determine the effect of injection. The percentage reduction of each mediator was calculated compared with the control side for intergroup comparison then the correlation between SP and IL-6 levels was analyzed using Spearman's rank order correlation coefficient. Statistical analysis was performed, and the significance level was set at p<0.05. RESULTS: Submucosal cryotherapy, dexamethasone sodium phosphate, and diclofenac sodium significantly reduced SP and IL-6 pulpal release. Submucosal cryotherapy significantly reduced SP more than and IL-6 more than dexamethasone sodium phosphate and diclofenac sodium. Pulpal reduction of SP and IL-6 showed a strong positive significant correlation. CONCLUSIONS: Submucosal cryotherapy reduces the pulpal release of SP and IL-6 and could be tested as an alternative to premedication to potentiate the effect of anesthesia and control postoperative endodontic pain.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal , Cryotherapy , Dental Pulp , Dexamethasone , Diclofenac , Enzyme-Linked Immunosorbent Assay , Interleukin-6 , Pulpitis , Random Allocation , Substance P , Animals , Rabbits , Pulpitis/therapy , Diclofenac/pharmacology , Dexamethasone/pharmacology , Dexamethasone/analogs & derivatives , Interleukin-6/analysis , Cryotherapy/methods , Substance P/analysis , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Dental Pulp/drug effects , Time Factors , Reproducibility of Results , Treatment Outcome , Male , Statistics, Nonparametric , Disease Models, Animal , Anti-Inflammatory Agents/pharmacology , Saline Solution , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL